Low - Molecular Weight Heparins and Unfractionated Heparins during Primary Coronary Intervention

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 11, Iss. 2, 2013-06 ,pp. : 96-100

Bentham Science Publishers

Access to resources Recommend Favorite

Markers of hemostatic system activation during treatment of deep vein thrombosis with subcutaneous unfractionated or low-molecular weight heparin

By Peternel P.   Terbizan M.   Tratar G.   Bozic M.   Horvat D.   Salobir B.   Stegnar M.  

Thrombosis Research, Vol. 105, Iss. 3, 2002-02 ,pp. : 241-246

Elsevier

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin Successfully Used to Treat a Nephrotic Patient Complicated by Superior Mesenteric Vein Thrombosis and Portal Vein Thrombosis

By  

Medical Principles and Practice, Vol. 20, Iss. 2, 2011-01 ,pp. : 196-199

Karger

Access to resources Recommend Favorite

Low-Molecular-Weight-Heparins: A Review of Literature

By  

Vascular Disease Prevention, Vol. 5, Iss. 3, 2008-08 ,pp. : 190-199

Bentham Science Publishers

Access to resources Recommend Favorite

Low-Molecular-Weight Heparins in Acute Coronary Syndromes

By  

Current Vascular Pharmacology, Vol. 1, Iss. 3, 2003-10 ,pp. : 259-271

Bentham Science Publishers

Access to resources Recommend Favorite